Phage therapy: a potential breakthrough in Tuberculosis treatment
To the Editor, Tuberculosis (TB) is the second leading cause of mortality worldwide from a single infectious agent1. According to the WHO, it has infected over 10.6 million people worldwide, leading to 1.30 million deaths in 20221. Antibiotics are the primary treatment; however, multidrug-resista...
Saved in:
| Main Authors: | Muhammad Aliyan Ahmed, Yasir Ahmad |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Pakistan Medical Association
2025-03-01
|
| Series: | Journal of the Pakistan Medical Association |
| Subjects: | |
| Online Access: | https://jpma.org.pk/index.php/public_html/article/view/21831 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Advances and prospects for treatment strategies of drug-resistant tuberculosis: a review
by: Michalik, Maciej, et al.
Published: (2025-06-01) -
Drug resistance pattern, prevalence and risk factors for resistance to second line anti-tuberculosis drugs in Balochistan, Pakistan
by: Naila Samad, et al.
Published: (2024-09-01) -
The Profile of Multidrug Tuberculosis Regimen and Treatment Outcomes in Pulmonary MDR-TB Patients at the Tertiary Referral Hospital Dr. Soetomo, East Java, Indonesia: A Seven-Year Retrospective Study on Bedaquiline
by: Muhamad Frendy Setyawan, et al.
Published: (2024-01-01) -
People Who Inject Drugs and have tuberculosis: Opioid Substitution Therapy improves treatment outcomes in Ukraine
by: Tetiana Fomenko, et al.
Published: (2021-09-01) -
Bedaquiline practice in treatment of extensively drug-resistant mycobacterium tuberculosis in children: Clinical cases
by: A. A. Akzhigitova, et al.
Published: (2022-05-01)